BMS Exec Charged with Insider Trading

X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Bristol-Myers Squibb Co. executive Robert Ramnarine was charged with insider trading for making $311,361 in illegal profit by buying stock options in three companies targeted for acquisition.

Recommended Stories

Can Congress Block Tariffs?

Mark Niquette |

Business groups line up behind proposed legislation that would limit Trump's tariff powers.

Brexit Talks Will Continue into 2019

Tim Ross, Robert Hutton, & Alex Morales |

Still hoping for more concessions from the EU, May will finally put the deal to a vote in the week of January 14.

Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
  • Terms of Service
  • Privacy Policy

    • Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.